fda crackdown on compounded semaglutide How Crackdowns Are Affecting GLP-1 Use In 2025 FDA cracks down on 'misleading'

The GLP-1RA group has reduced breath alcohol concentration (BrAC) and subjective feeling ratings during an alcohol administration session To understand the effects of GLP-1RAs on alcohol absorption and its subjective effects, we compared BrAC and subjective feelings of intoxication between groups

Weeks 9 through 12 Total weight loss from a 4 to 6mg Retatrutide protocol over this period often lands in the 15 to 25 lb range depending on starting weight, protocol adherence, and diet quality

Nevadunsky NS, Van Arsdale A, Strickler HD, et al

Major Differences to Consider Receptor Activation Retatrutide: GLP-1 + GIP + glucagon Semaglutide: GLP-1 only Expected Weight Loss Retatrutide: Potentially greater reductions Semaglutide: Strong but less dramatic Side-Effect Profile Retatrutide may produce more intense gastrointestinal symptoms early on due to its multi-receptor activation

We're now seeing research into 'tri-agonists' and other combination molecules that could offer even greater efficacy, potentially with different dosing profiles

Central appetite regulation Hypothalamic GLP-1R activation reduces hunger and food reward